Fundraising Fox

AdvanDx

Woburn, US · Delaware corporation · 1 known investors

Founders & leadership

DB
Donald B. HawthorneExecutive
TP
Thomas P. KellyExecutive

Board

DH
Dennis H. LangerBoard director
CD
Christopher D. EarlBoard director
DM
David M. RubinBoard director
LT
Lars TonnesenBoard director
HA
Hans AndreassonBoard director
HD
Heiner DreismannBoard director
TB
Thierry BernardBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$11.6M disclosed across 2 rounds · 2014–2015

$2.5MraisedMar 2015 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lars TonnesenDirector
  • Dennis H. LangerDirector
  • Hans AndreassonDirector
  • Christopher D. EarlDirector
  • Donald B. HawthorneExecutive Officer
  • Heiner DreismannDirector
  • David M. RubinDirector
  • Thierry BernardDirector
Offering amount
$2.5M
Amount sold
$2.5M
First sale
Feb 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$9.1MraisedApr 2014 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas P. KellyExecutive Officer
  • Heiner DreismannDirector
  • Hans AndreassonDirector
  • Lars TonnesenDirector
  • Dennis H. LangerExecutive Officer, Director
Offering amount
$12.1M
Amount sold
$9.1M
First sale
Mar 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

Who are AdvanDx's investors?
AdvanDx's investors include Merck Global Health Innovation Fund.
How much funding has AdvanDx raised?
AdvanDx has disclosed $11.6M raised across 2 rounds.
Where is AdvanDx headquartered?
AdvanDx is headquartered in Woburn, US.